Nexentis Technologies fair value
None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Nexentis Technologies today, so there is nothing to project yet.
Peers
Pharmaceutical Preparations · Pick stocks to compare with NXTS
Spot a number that looks wrong? Check it in NXTS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NXTS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.